Investigating a gMG Therapy, Part 1: The MG-ADL Results
Christyn Edmundson, MD
PeerInvestigating a gMG Therapy, Part 3: Results from the Extension Studies
Christyn Edmundson, MD
PeerInvestigating a gMG Therapy, Part 2: The Secondary Endpoint Results, Including MG Symptoms PRO
Christyn Edmundson, MD
PeerFrom Symptoms to Diagnosis: Navigating ATTR Amyloidosis in Clinical Practice
Unraveling Hereditary ATTR Amyloidosis: Key Variants and Clinical Insights
Improving Outcomes in hATTR-PN: The Role of Vigilant Symptom Assessment
Beyond Plaques: Current Concepts in Alzheimer’s Pathophysiology
The Time Is Now: Early Diagnosis and Intervention in Alzheimer’s Disease
Recognizing Agitation in Alzheimer’s Dementia: A Screening Tool for Caregivers
Managing NF1 PN with this First and Only FDA-Approved Treatment Option
Hand-in-Hand: Walking Patients Through Their Journey with a Therapy for Early Alzheimer’s Disease (AD)
Gregory Cooper, MD, PhD
PeerPatient-Centric Care for Managing Certain Manifestations of VHL Disease
Navigating PTSD: Expert Insights on Diagnosis and Challenges
PTSD Unmet Needs: A Lens on Burden, Impact, and Treatment Challenges